General Information of the Compound
Compound ID
CP0405207
Compound Name
4-decyl-N-pyridin-3-ylbenzamide
    Show/Hide
Synonyms
4-decyl-N-(pyridin-3-yl)benzamide
CHEMBL259102
    Show/Hide
Structure
Formula
C22H30N2O
Molecular Weight
338.495
Canonical SMILES
CCCCCCCCCCc1ccc(cc1)C(=O)Nc1cccnc1
    Show/Hide
InChI
InChI=1S/C22H30N2O/c1-2-3-4-5-6-7-8-9-11-19-13-15-20(16-14-19)22(25)24-21-12-10-17-23-18-21/h10,12-18H,2-9,11H2,1H3,(H,24,25)
    Show/Hide
InChIKey
QIODTOXMQFMJNV-UHFFFAOYSA-N
Physicochemical Property
logP
6.0171
Rotatable Bonds
11
Heavy Atom Count
25
Polar Areas
41.99
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44450381
ChEMBL ID
CHEMBL259102
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
EC50 > 30000 nM
   TI
   LI
   LO
   TS
2
Ki = 607 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-decyl-N-(pyridin-3-yl)benzamide )
Drug Name 4-decyl-N-(pyridin-3-yl)benzamide
Target(s)
Transient receptor potential cation channel V1 (TRPV1)
Inhibitor